Loading...
If your product does not perform as described on this datasheet, we will refund or replace your product...
Read our guarantee »Products:Signal Transduction >> Protein Trafficking >> Vesicle Transport >> Regulation
Anti-VAPB antibody
See all VAPB products (4) ...
Rabbit polyclonal to VAPB
WB, IHC-Fr, IHC-Pmore details
Reacts with
Mouse, Rat, Human
Predicted to work with
Chicken, Cow, Xenopus laevis, Zebrafish
A synthetic peptide from a cytoplasmic part (middle region) of VAPB conjugated to an immunogenic carrier protein. The peptide is homologous in many species including human, rat, mouse, zebrafish, cow, xenopus and chicken.
Liquid
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C (add glycerol to a final volume of 40% for extra stability). Avoid repeated freeze / thaw cycles.
Preservative: None
Constituents: 1X PBS
Concentration information loading...
IgG fraction
Polyclonal
IgG
Cancer >> Cancer Metabolism >> Metabolic signaling pathway >> Metabolism of lipids and lipoproteins
Signal Transduction >> Protein Trafficking >> Vesicle Transport >> Regulation
Our Abpromise guarantee covers the use of ab72470 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
IHC-Fr: Use at a concentration of 10 - 50 µg/ml. Antigen retrieval is recommended.
IHC-P: Use at a concentration of 10 - 50 µg/ml.
WB: Use at a concentration of 10 - 50 µg/ml. Predicted molecular weight: 27 kDa.
Not yet tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.
VAPB contains 1 MSP domain and it may play a role in vesicle trafficking. Defects in VAPB are a cause of proximal adult autosomal dominant spinal muscular atrophy [MIM:182980]; also called late onset spinal muscular atrophy Finkel type. Spinal muscular atrophies are neurodegenerative disorders characterized by degeneration of lower motor neurons, leading to progressive paralysis muscular atrophy. This form is a late adult onset form of the disease (after age 20 years). The patients show a benign course, most of them remaining ambulatory 10 to 40 years after clinical onset.
Cell membrane; Single-pass type IV membrane. Intracytoplasmic membrane; Single-pass type IV membrane protein. Note: Present in the plasma membrane and in intracellular vesicles.
ab72470 has not yet been referenced specifically in any publications.
Publishing research using ab72470? Please let us know so that we can cite the reference in this datasheet
Concentration of lot no. is
Concentration not available for this lot.
Find concentration of your lot:
0
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Call 01223 696 000 or contact us
